Cingulate Inc. (CING) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -28.80M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-28.80M | (m) |
| 2026-03-31 | (m) | $-27.91M | (m) |
| 2025-12-31 | (m) | $-22.45M | (m) |
| 2025-09-30 | (m) | $-21.39M | (m) |
| 2025-06-30 | (m) | $-17.96M | (m) |
| 2025-03-31 | (m) | $-16.38M | (m) |
| 2024-12-31 | (m) | $-15.55M | (m) |
| 2024-09-30 | (m) | $-16.35M | (m) |
| 2024-06-30 | (m) | $-19.10M | (m) |
| 2024-03-31 | (m) | $-22.50M | (m) |
| 2023-12-31 | (m) | $-23.53M | (m) |
| 2023-09-30 | (m) | $-21.21M | (m) |
| 2023-06-30 | (m) | $-19.25M | (m) |
| 2023-03-31 | (m) | $-16.68M | (m) |
| 2022-12-31 | (m) | $-17.68M | (m) |
| 2022-09-30 | (m) | $-15.72M | (m) |
| 2022-06-30 | (m) | $-26.99M | (m) |
| 2022-03-31 | (m) | $-24.38M | (m) |
| 2021-12-31 | (m) | $-20.71M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-7.18M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |